Envestnet Asset Management
IDYA icon

Envestnet Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Envestnet Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.35M Sell
224,109
-32,209
-13% -$986K ﹤0.01% 2061
2026
Q1 		$8.54M Sell
256,318
-21,242
-8% -$713K ﹤0.01% 1932
2025
Q4 		$9.6M Sell
277,560
-21,472
-7% -$685K ﹤0.01% 1718
2025
Q3 		$8.14M Buy
299,032
+189,877
+174% +$4.59M ﹤0.01% 1906
2025
Q2 		$2.29M Buy
109,155
+11,752
+12% +$225K ﹤0.01% 2730
2025
Q1 		$1.6M Buy
97,403
+132
+0.1% +$2.81K ﹤0.01% 2881
2024
Q4 		$2.5M Sell
97,271
-11,342
-10% -$321K ﹤0.01% 2558
2024
Q3 		$3.44M Buy
108,613
+4,060
+4% +$154K ﹤0.01% 2337
2024
Q2 		$3.67M Buy
104,553
+20,607
+25% +$816K ﹤0.01% 2232
2024
Q1 		$3.68M Buy
+83,946
New +$3.61M ﹤0.01% 2191

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Envestnet Asset Management's IDYA Position: Q2 2026 in Review

Envestnet Asset Management reduced its IDEAYA Biosciences (IDYA) stake by 13% in Q2 2026, selling an estimated $986K and leaving 224,109 shares worth $8.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2061.

Envestnet Asset Management first reported a position in IDYA in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.6M in Q4 2025. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Envestnet Asset Management held 224,109 shares of IDEAYA Biosciences worth $8.35M as of Q2 2026.
  • Envestnet Asset Management sold 32,209 IDEAYA Biosciences shares in Q2 2026, an estimated $986K.
  • IDEAYA Biosciences made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2061 holding.
  • Envestnet Asset Management first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 10 quarters since.
  • Envestnet Asset Management's IDEAYA Biosciences position peaked at $9.6M in Q4 2025.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.